144 filings
Page 4 of 8
F-3
k1mflil 9xqf8xzo
3 Nov 20
Shelf registration (foreign)
8:24am
6-K
5wywzv89gwwv ev
22 Sep 20
BeyondSpring Appoints Elizabeth Czerepak as Chief Financial Officer
5:22pm
6-K
j1o8why7ev 7x5
3 Sep 20
BeyondSpring Provides Second-Quarter 2020 Financial Results and Business Updates
8:00am
6-K
csrzzlijly sf1j
19 Aug 20
BeyondSpring Appoints Forty Seven, Inc., Co-Founder and Stanford Hematology Veteran, Dr. Ravindra Majeti, to Board of Directors
6:43am
S-8
w5ck90
24 Jul 20
Registration of securities for employees
4:05pm
6-K
b5a1p4b zt01g
24 Jul 20
Current report (foreign)
4:03pm
6-K
sab74
23 Jun 20
Current report (foreign)
4:09pm
424B5
bitmrejj3oa18ivanv
19 Jun 20
Prospectus supplement for primary offering
4:31pm
424B5
e1d8012
18 Jun 20
Prospectus supplement for primary offering
4:40pm
6-K
qtgk2s82rlc
15 Jun 20
Current report (foreign)
4:39pm
6-K
w82yjjz 8v
11 Jun 20
BeyondSpring Reports First-Quarter 2020 Financial Results and Operational Update
4:15pm
6-K
ml8rppvu1377mty
11 Mar 20
BeyondSpring Files for Patent Protection on BPI-002 for the Treatment of Viral Infections Including COVID-19
4:01pm
6-K
nlmiyze3 q96m4
7 Feb 20
Current report (foreign)
5:14pm
424B5
2bjhbqhwlk4ckdrpjouv
7 Feb 20
Prospectus supplement for primary offering
4:16pm
6-K
dy8zbsck hfr
23 Jan 20
BeyondSpring Appoints Pharma Veterans Drs. Daniel Zabrowski and Ramon Mohanlal to Company’s Board of Directors
8:00am
6-K
svajzx9j0cl0tg7e6ds
18 Dec 19
BeyondSpring Provides Third-Quarter 2019 Operational and Financial Results Update
8:01am
6-K
hs796l wr13
29 Oct 19
Current report (foreign)
4:05pm
424B5
d0trw2 xv4rik
28 Oct 19
Prospectus supplement for primary offering
4:02pm
424B5
ryw jfm4hr77y
25 Oct 19
Prospectus supplement for primary offering
12:00am